ARTICLE | Clinical News
Xtandi enzalutamide regulatory update
August 19, 2013 7:00 AM UTC
Medivation disclosed in its 2Q13 earnings that it submitted regulatory applications in Argentina, Australia, Brazil, South Africa and Switzerland for Xtandi enzalutamide to treat metastatic castration...